Reports
Reports
Sale
The global endometrial ablation market is expected to grow at a CAGR of 7.30% during the forecast period of 2024-2032, driven by the rising incidence of gynaecological disorders along with the growing preference for minimally invasive procedures across the globe.
Endometrial ablation is the procedure of removing the innermost lining (endometrium) of the uterus. It is done to reduce the heavy flow of blood during menstruation, mostly in menopausal or post-menopausal women or in women with fibroids, polyps, uterine or endometrial cancer. Endometrial ablation is a non-surgical procedure, where the healthcare provider may use a slender tool to enter the uterus via a vaginal opening, without making any incision.
The rising patient inclination towards minimally invasive procedures such as endometrial ablation due to reduced risk of complications and shorter recovery period is fueling the market demand. The market is also experiencing a growing preference for second-generation endometrial ablation techniques, which are based on using thermal fluid, laser thermotherapy, and cryoablation, among others. Moreover, the increasing prevalence of gynecological disorders, rising advancements in ablation technology, and the growing emphasis on women’s reproductive health are some of the factors driving the market growth.
Increasing Burden of Gynecological Disorders is Expected to Affect the Market Landscape
There is a significant rise in the incidence and prevalence of gynecological disorders which is prompting many women to seek advanced and effective treatments such as endometrial ablation methods. Recent data reveals that up to one-third of women will be affected by abnormal uterine bleeding in their lives. The prevalence of abnormal uterine bleeding is estimated to be between 3% to 30% among reproductive-aged women, with the incidence increasing around menarche and perimenopause. Since endometrial ablation is a relatively painless procedure that can be performed quickly in an outpatient setting and offers several benefits such as minimal recovery time, its market demand is likely to witness a surge in the coming years.
Rising Technological Innovations Elevate the Endometrial Ablation Market Value
In February 2023, the United States based medical technology company Hologic, Inc., announced the approval of its endometrial ablation (GEA) device NovaSure V5 in Canada and Europe. This next-generation technology is a newer version of the company’s existing NovaSure device to treat abnormal uterine bleeding in women. NovaSure V5 is incorporated with improved features, including a patient-centric design and SmartDepth™ technology, with an average treatment time of around 90 seconds. The device has demonstrated impressive clinical performance, with 97% patient satisfaction and a 75% amenorrhea rate after five years. The surge in the launch of such innovative endometrial ablation technologies is elevating the market value.
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Trends | Impact |
Rising Demand for Minimally Invasive Procedures | There is a growing market trend towards the preference for minimally invasive techniques compared to major surgical techniques procedures such as hysterectomy. The minimally invasive nature of endometrial ablation is a major driver of its market demand due to associated benefits, such as shorter recovery times, lower risk of complications, reduced menstrual bleeding, and improved quality of patient life |
Increasing Investments in Women’s Health | One of the significant market trends is the increased investments in women's health initiatives both by the governments and private organizations, intending to improve gynecological care and outcomes. Such substantial investments are leading to the introduction of advanced treatments in healthcare facilities, thereby impacting the endometrial ablation market demand. |
Heightened Awareness Surrounding Women’s Reproductive Health | The increasing awareness about reproductive health is leading to growing acceptance of endometrial ablation as a viable treatment option for abnormal uterine bleeding. Further, educational campaigns and initiatives by healthcare providers and organizations are resulting in increased recognition of the procedure and its benefits, influencing its adoption rates. |
Shift towards Non-Hormonal Treatments | The market growth is affected by the rising shift towards non-hormonal treatments to treat and manage abnormal uterine bleeding instead of relying on traditional treatments such as hormonal therapies. Endometrial ablation offers an effective non-hormonal alternative, making it a popular choice among patients experiencing gynecological problems. |
Market Breakup by Type
Market Breakup by Indication
Market Breakup by End User
Market Breakup by Region
Market Segmentation Based on Type is Anticipated to Witness Substantial Growth
The market segmentation by type includes radiofrequency ablation, cryoablation, microwave ablation, hydrothermal ablation, thermal balloon ablation, laser ablation, and electrical ablation, among others. These ablation procedures leverage heat or cold-based technologies to destroy the endometrium. Several second-generation modalities have entered the market such as hydrothermal, radiofrequency, microwave, and cryotherapy. Cryotherapy, which uses cooling technology to gently destroy the endometrial lining, offers many advantages such as minimal scarring inside the uterus as compared to heat-based ablation techniques. The rising advancements in ablation technologies that reduce the risk of scarring and pelvic pain are expected to augment the market size.
Abnormal Uterine Bleeding and Menorrhagia Segment are Boosting the Market Share
Based on indication, the market is segmented into abnormal uterine bleeding, menorrhagia, adenomyosis, and endometrial hyperplasia. The increasing prevalence and diagnosis of gynecological conditions such as abnormal uterine bleeding (AUB) and menorrhagia directly impact the market demand. Endometrial ablation is increasingly preferred as a treatment option for several indications due to its efficacy in controlling heavy periods and improving quality of life.
Based on the region, the market covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominates the market share owing to the rising incidence of gynecological disorders which can be attributed to a sedentary lifestyle, dietary changes, and indulgence in alcohol, among others. The presence of a well-established healthcare system that entails advanced infrastructure for treatment and further research is contributing significantly to the market growth in the region.
Asia Pacific is also witnessing rapid endometrial ablation market growth driven by rising healthcare expenditure and increased women-centric health initiatives supported by the government. For example, the Indian government has been quite proactive by setting up outreach camps, and national mobile medical units, and launched various schemes like the Janani Shishu Suraksha Karyakram (JSSK) and Surakshit Matritva Aashwasan (SUMAN), with the aim to spread awareness on women’s reproductive health. Such initiatives are poised to boost market share in the forecast period.
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
AEGEA Medical, Inc.
AEGEA Medical, Inc. is a prominent player in the market, known for its innovative FDA-approved Mara™ Water Vapor Ablation System (a two-minute, in-office treatment that ablates the uterus lining). The company was acquired by a leading fertility and women's health company CooperSurgical, Inc. in 2021.
Boston Scientific Corporation
The global medical technology leader has introduced innovative medical solutions such as the next-generation Genesys HTA™ System for the treatment of menorrhagia in the market.
CooperSurgical, Inc.
CooperSurgical, Inc., one of the business units of CooperCompanies, specializes in women's health and fertility solutions. Their advanced endometrial ablation device, the Her Option Uterine Cryoablation Therapy System, utilizes cryoablation technology to treat abnormal uterine bleeding.
Hologic, Inc.
This United States-based medical technology company is primarily focused on women's health. The company's NovaSure Advanced Endometrial Ablation System is a popular product in the market.
Other key players in the market include IDOMAN-MED, Minerva Surgical, Inc., Olympus Corporation, Omnitech Systems, Inc., Medtronic, Richard Wolf, Smith & Nephew, and Ethicon.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Type |
|
Breakup by Indication |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Middle East and Africa Neonatal Ventilators Market Size
Middle East and Africa Neonatal Ventilators Market Growth
Middle East and Africa Neonatal Ventilators Market Trends
Middle East and Africa Neonatal Ventilators Market Share
Middle East and Africa Neonatal Ventilators Market Regional Analysis
Middle East and Africa Neonatal Ventilators Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Endometrial Ablation Market Overview
3.1 Global Endometrial Ablation Market Historical Value (2017-2023)
3.2 Global Endometrial Ablation Market Forecast Value (2024-2032)
4 Global Endometrial Ablation Market Landscape*
4.1 Global Endometrial Ablation: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Endometrial Ablation: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Indication
5 Global Endometrial Ablation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Endometrial Ablation Market Segmentation (2017-2032)
6.1 Global Endometrial Ablation Market (2017-2032) by Type
6.1.1 Market Overview
6.1.2 Radiofrequency Ablation
6.1.3 Cryoablation
6.1.4 Microwave Ablation
6.1.5 Hydrothermal Ablation
6.1.6 Thermal Balloon Ablation
6.1.7 Laser Ablation
6.1.8 Electrical Ablation
6.1.9 Others
6.2 Global Endometrial Ablation Market (2017-2032) by Indication
6.2.1 Market Overview
6.2.2 Abnormal Uterine Bleeding
6.2.3 Menorrhagia
6.2.4 Adenomyosis
6.2.5 Endometrial Hyperplasia
6.3 Global Endometrial Ablation Market (2017-2032) by End User
6.3.1 Market Overview
6.3.2 Hospitals
6.3.3 Clinics
6.3.4 Ambulatory Surgical Centers
6.3.5 Others
6.4 Global Endometrial Ablation Market (2017-2032) by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Endometrial Ablation Market (2017-2032)
7.1 North America Endometrial Ablation Market (2017-2032) by Type
7.1.1 Market Overview
7.1.2 Radiofrequency Ablation
7.1.3 Cryoablation
7.1.4 Microwave Ablation
7.1.5 Hydrothermal Ablation
7.1.6 Thermal Balloon Ablation
7.1.7 Laser Ablation
7.1.8 Electrical Ablation
7.1.9 Others
7.2 North America Endometrial Ablation Market (2017-2032) by Indication
7.2.1 Market Overview
7.2.2 Abnormal Uterine Bleeding
7.2.3 Menorrhagia
7.2.4 Adenomyosis
7.2.5 Endometrial Hyperplasia
7.3 North America Endometrial Ablation Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Endometrial Ablation Market (2017-2032)
8.1 Europe Endometrial Ablation Market (2017-2032) by Type
8.1.1 Market Overview
8.1.2 Radiofrequency Ablation
8.1.3 Cryoablation
8.1.4 Microwave Ablation
8.1.5 Hydrothermal Ablation
8.1.6 Thermal Balloon Ablation
8.1.7 Laser Ablation
8.1.8 Electrical Ablation
8.1.9 Others
8.2 Europe Endometrial Ablation Market (2017-2032) by Indication
8.2.1 Market Overview
8.2.2 Abnormal Uterine Bleeding
8.2.3 Menorrhagia
8.2.4 Adenomyosis
8.2.5 Endometrial Hyperplasia
8.3 Europe Endometrial Ablation Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Endometrial Ablation Market (2017-2032)
9.1 Asia Pacific Endometrial Ablation Market (2017-2032) by Type
9.1.1 Market Overview
9.1.2 Radiofrequency Ablation
9.1.3 Cryoablation
9.1.4 Microwave Ablation
9.1.5 Hydrothermal Ablation
9.1.6 Thermal Balloon Ablation
9.1.7 Laser Ablation
9.1.8 Electrical Ablation
9.1.9 Others
9.2 Asia Pacific Endometrial Ablation Market (2017-2032) by Indication
9.2.1 Market Overview
9.2.2 Abnormal Uterine Bleeding
9.2.3 Menorrhagia
9.2.4 Adenomyosis
9.2.5 Endometrial Hyperplasia
9.3 Asia Pacific Endometrial Ablation Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Endometrial Ablation Market (2017-2032)
10.1 Latin America Endometrial Ablation Market (2017-2032) by Type
10.1.1 Market Overview
10.1.2 Radiofrequency Ablation
10.1.3 Cryoablation
10.1.4 Microwave Ablation
10.1.5 Hydrothermal Ablation
10.1.6 Thermal Balloon Ablation
10.1.7 Laser Ablation
10.1.8 Electrical Ablation
10.1.9 Others
10.2 Latin America Endometrial Ablation Market (2017-2032) by Indication
10.2.1 Market Overview
10.2.2 Abnormal Uterine Bleeding
10.2.3 Menorrhagia
10.2.4 Adenomyosis
10.2.5 Endometrial Hyperplasia
10.3 Latin America Endometrial Ablation Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Endometrial Ablation Market (2017-2032)
11.1 Middle East and Africa Endometrial Ablation Market (2017-2032) by Type
11.1.1 Market Overview
11.1.2 Radiofrequency Ablation
11.1.3 Cryoablation
11.1.4 Microwave Ablation
11.1.5 Hydrothermal Ablation
11.1.6 Thermal Balloon Ablation
11.1.7 Laser Ablation
11.1.8 Electrical Ablation
11.1.9 Others
11.2 Middle East and Africa Endometrial Ablation Market (2017-2032) by Indication
11.2.1 Market Overview
11.2.2 Abnormal Uterine Bleeding
11.2.3 Menorrhagia
11.2.4 Adenomyosis
11.2.5 Endometrial Hyperplasia
11.3 Middle East and Africa Endometrial Ablation Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Market Share by Top 5 Comapnies
17.2 AEGEA Medical, Inc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Boston Scientific Corporation
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 CooperSurgical, Inc.
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Hologic, Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 IDOMAN-MED
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Minerva Surgical, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Olympus Corporation
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Omnitech Systems, Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications Mergers and Acquisitions
17.9.6 Certifications
17.10 Medtronic
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Richard Wolf
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Smith & Nephew
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Ethicon
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Endometrial Ablation Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.